Clinical Trial Update: High-dose Cephalexin for Cellulitis (HI-DOCC) [Phase 4]

View source ↗

Summary

A Phase 4 trial in enrollment by invitation is evaluating high-dose cephalexin for cellulitis at the Ottawa Hospital Research Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulitis

Drugs mentioned

• Cephalexin (Cephalexin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Cellulitis | Phase 4 | Status: ENROLLING_BY_INVITATION